Recombinant Cynomolgus Monkey FCAR/CD89 Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 9516-FA

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
9516-FA-050
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

NS0

Accession #

XP_005590398.1

Conjugate

Unconjugated

Applications

Bioactivity

View all FCAR/CD89 Proteins and Enzymes »

Product Specifications

Source

Mouse myeloma cell line, NS0-derived cynomolgus monkey FCAR/CD89 protein
Gln22-Asn227, with a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

No reults obtained. Gln 22 inferred from enzymatic pyroglutamate treatment revealing Glu23

Predicted Molecular Mass

24 kDa

SDS-PAGE

33-70 kDa, under reducing conditions.

Activity

Measured by its binding ability in a functional ELISA.
When Human IgA is immobilized at 5 μg/mL, 100 μL/well, the concentration of Recombinant Cynomolgus Monkey FCAR/CD89 that produces 50% of the optimal binding response is 0.250-2.50  μg/mL.

Scientific Data Images for Recombinant Cynomolgus Monkey FCAR/CD89 Protein, CF

Recombinant Cynomolgus Monkey FCAR/CD89 Protein Bioactivity

Recombinant Cynomolgus Monkey FCAR/CD89 Protein Bioactivity

When Human IgA is coated at 5 µg/mL (100 μL/well), Recombinant Cynomolgus Monkey FCAR/CD89 (Catalog # 9516-FA) binds with an ED50 of 0.250-2.50 μg/mL.

Formulation, Preparation and Storage

9516-FA
Formulation Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Reconstitution
Reconstitute at 200 μg/mL in PBS.

Reconstitution Buffer Available:
Size / Price
Qty
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: FCAR/CD89

FCAR, also called Fc alpha RI or CD89, is a variably glycosylated 50-100 kDa myeloid-specific type I transmembrane (TM) Fc receptor for IgA and is a member of the multi-chain immune recognition receptor (MIRR) family (1-3). Cynomolgus FCAR is predicted to contain a 21 amino acid (aa) signal sequence and 206 aa extracellular (ECD), 19 aa TM and 41 aa cytoplasmic domains (4). The Arg230 within the TM domain of human FCAR supports interaction with the ITAM-containing signaling subunit, FcR gamma, which contains a TM Asp (5-7). Two ECD C2-type Ig-like domains (EC1 and 2) are oriented at right angles (8). Up to two molecules of FCAR can bind one molecule of serum IgA via EC1 (8). Many human FCAR splice variants have been reported, but only two have been identified as proteins (9, 10). The a.2 form, which lacks 22 aa just prior to the TM domain, is exclusively expressed in alveolar macrophages. The a.3 form lacks EC2. FCAR binds monomeric, polymeric and secretory IgA, but does not mediate the barrier function of secretory IgA in mucosal epithelium (1-3). Shedding and circulation of polymeric IgA/FCAR immune complexes has been reported (11). Circulating neutrophils, eosinophils, and monocytes express FCAR (12). Tissue expression of FCAR is mainly from neutrophils; FCAR is down-regulated as monocytes differentiate to tissue macrophages (12). On neutrophils, a significant amount of FCAR lacks FcR gamma, but can still be endocytosed to early endosomes and recycled to the cell surface (5). Binding of serum IgA to FCAR is transient and anti-inflammatory, inhibiting IgG or IgE-induced degranulation (6). Sustained aggregation of FCAR results in inflammatory responses (6). FcR gamma signaling is required for these and for transport to late endosomes (5-7). Within ECD, Cynomolgus FCAR shows 83% aa identity with human FCAR. No ortholog occurs in mouse. FCAR structure resembles the KIR/ILT/LIR/MIR family more than other IgA receptors, including pIgR, Fc alpha /μR, asialoglycoprotein receptor (ASGR1) and transferrin receptor (TfR) (1-3).

References

  1. Wines, B. D. and P. M. Hogarth (2006) Tissue Antigens 68:103.
  2. Otten, M. A. and M. van Egmon (2004) Immunol. Lett. 92:23.
  3. Montiero, R. C. and J. G. J. van de Winkel (2003) Annu. Rev. Immunol. 21:177.
  4. Maliszewski, C. R. et al. (1990) J. Exp. Med. 172:1665.
  5. Launay, P. et al. (1999) J. Biol. Chem. 274:7216.
  6. Pasquier, B. et al. (2005) Immunity 22:31.
  7. Shen, L. et al. (2001) Blood 97:205.
  8. Herr, Y. et al. (2003) Nature 423:614.
  9. Patry, C. et al. (1996) J. Immunol. 156:4442.
  10. Togo, S. et al. (2003) FEBS Lett. 535:205.
  11. van der Boog, P. J. M. et al. (2002) J. Immunol. 168:1252.
  12. Hamre, R. et al. (2003) Scand. J. Immunol. 57:506.

Long Name

IgA Fc Receptor

Alternate Names

CD89

Entrez Gene IDs

2204 (Human); 365183 (Rat); 102145896 (Cynomolgus Monkey)

Gene Symbol

FCAR

UniProt

XP_005590398.1

Additional FCAR/CD89 Products

Product Documents for Recombinant Cynomolgus Monkey FCAR/CD89 Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Cynomolgus Monkey FCAR/CD89 Protein, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.